Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more ...

On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...

Overview Effect of Narcotics on Respiratory Physiology Treatment of Opioid-Induced Sleep-Disordered Breathing References Treatment of Opioid-Induced Sleep-Disordered Breathing The treatment of ...